Literature DB >> 21935284

Dopa-responsive dystonia with a novel initiation codon mutation in the GCH1 gene misdiagnosed as cerebral palsy.

Jae-Hyeok Lee1, Chang-Seok Ki, Dae-Seong Kim, Jae-Wook Cho, Kyung-Phil Park, Seonhye Kim.   

Abstract

Dopa-responsive dystonia (DRD) is a clinical syndrome characterized by childhood-onset dystonia and a dramatic response to relatively low doses of levodopa. However, patients with DRD can be misdiagnosed as cerebral palsy or spastic diplegia due to phenotypic variation. Here we report a young woman with DRD who were severely disabled and misdiagnosed as cerebral palsy for over 10 yr. A small dose of levodopa restored wheelchair-bound state to normality. However, thoracolumbar scoliosis has remained as a sequel due to late detection of DRD. Genetic analysis by using PCR-direct sequencing revealed a novel initiation codon mutation (c.1A>T; p.Met1Leu) in GTP cyclohydrolase 1 (GCH1) gene. Although it is known that DRD can be misdiagnosed as cerebral palsy, this case reinforces the importance of differential diagnosis of DRD from cerebral palsy.

Entities:  

Keywords:  Cerebral Palsy; Diagnostic Errors; Dystonia, Dopa-responsive; GCH1 Gene; Mutation

Mesh:

Substances:

Year:  2011        PMID: 21935284      PMCID: PMC3172666          DOI: 10.3346/jkms.2011.26.9.1244

Source DB:  PubMed          Journal:  J Korean Med Sci        ISSN: 1011-8934            Impact factor:   2.153


  14 in total

1.  A novel nonsense mutation of the GTP cyclohydrolase I gene in a family with dopa-responsive dystonia.

Authors:  K M Hong; Y S Kim; M K Paik
Journal:  Hum Hered       Date:  2001       Impact factor: 0.444

2.  Hereditary progressive dystonia with marked diurnal fluctuation.

Authors:  M Segawa; A Hosaka; F Miyagawa; Y Nomura; H Imai
Journal:  Adv Neurol       Date:  1976

3.  Four novel mutations in the GCH1 gene of Chinese patients with dopa-responsive dystonia.

Authors:  Li Cao; Lan Zheng; Wei-Guo Tang; Qin Xiao; Ting Zhang; Hui-Dong Tang; Song-Bin He; Xi-Jin Wang; Jian-Qing Ding; Sheng-Di Chen
Journal:  Mov Disord       Date:  2010-04-30       Impact factor: 10.338

4.  Clinical similarities of hereditary progressive/dopa responsive dystonia caused by different types of mutations in the GTP cyclohydrolase I gene.

Authors:  Y Tamaru; M Hirano; H Ito; J Kawamura; S Matsumoto; T Imai; S Ueno
Journal:  J Neurol Neurosurg Psychiatry       Date:  1998-04       Impact factor: 10.154

5.  Dopamine transporter density measured by [123I]beta-CIT single-photon emission computed tomography is normal in dopa-responsive dystonia.

Authors:  B S Jeon; J M Jeong; S S Park; J M Kim; Y S Chang; H C Song; K M Kim; K Y Yoon; M C Lee; S B Lee
Journal:  Ann Neurol       Date:  1998-06       Impact factor: 10.422

6.  Variability of clinical expression and evolution of spinal deformity in a family with late detection of dopa-responsive dystonia.

Authors:  Athanasios I Tsirikos; Lucinda J Carr; Hilali H Noordeen
Journal:  Dev Med Child Neurol       Date:  2004-02       Impact factor: 5.449

Review 7.  Autosomal dominant guanosine triphosphate cyclohydrolase I deficiency (Segawa disease).

Authors:  Masaya Segawa; Yoshiko Nomura; Nobuyoshi Nishiyama
Journal:  Ann Neurol       Date:  2003       Impact factor: 10.422

8.  Dopa-responsive dystonia: long-term treatment response and prognosis.

Authors:  T G Nygaard; C D Marsden; S Fahn
Journal:  Neurology       Date:  1991-02       Impact factor: 9.910

9.  A novel missense mutation of the GTP cyclohydrolase I gene in a Korean family with hereditary progressive dystonia/dopa-responsive dystonia.

Authors:  Ji-Hoon Kang; Sa-Yoon Kang; Hee-Kyoung Kang; Young-Sang Koh; Joo-Hyuk Im; Myoung Chong Lee
Journal:  Brain Dev       Date:  2004-08       Impact factor: 1.961

Review 10.  Dopa-responsive dystonia: a syndrome of selective nigrostriatal dopaminergic deficiency.

Authors:  B S Jeon
Journal:  J Korean Med Sci       Date:  1997-08       Impact factor: 2.153

View more
  7 in total

Review 1.  Genetic [corrected] insights into the causes and classification of [corrected] cerebral palsies.

Authors:  Andres Moreno-De-Luca; David H Ledbetter; Christa L Martin
Journal:  Lancet Neurol       Date:  2012-01-18       Impact factor: 44.182

Review 2.  Monoamine neurotransmitter disorders--clinical advances and future perspectives.

Authors:  Joanne Ng; Apostolos Papandreou; Simon J Heales; Manju A Kurian
Journal:  Nat Rev Neurol       Date:  2015-09-22       Impact factor: 42.937

3.  A Compound Heterozygote for GCH1 Mutation Represents a Case of Atypical Dopa-Responsive Dystonia.

Authors:  Subhajit Giri; Tufan Naiya; Shubhrajit Roy; Gautami Das; Gurusidheshwar M Wali; Shyamal Kumar Das; Kunal Ray; Jharna Ray
Journal:  J Mol Neurosci       Date:  2019-03-25       Impact factor: 3.444

4.  Botulinum Neurotoxin Injections in Childhood Opisthotonus.

Authors:  Mariam Hull; Mered Parnes; Joseph Jankovic
Journal:  Toxins (Basel)       Date:  2021-02-12       Impact factor: 4.546

5.  Dopa-responsive dystonia in a ten-year-old girl.

Authors:  Venkatesh Soma; Hussain Sadiq Mohammed; Ebrahim Riyas; Karuppasamy Murugesan
Journal:  J Family Med Prim Care       Date:  2012-07

Review 6.  Dystonic opisthotonus: a "red flag" for neurodegeneration with brain iron accumulation syndromes?

Authors:  Maria Stamelou; Scarlett C Lai; Annu Aggarwal; Susanne A Schneider; Henry Houlden; Tu-Hsueh Yeh; Amit Batla; Chin-Song Lu; Mohit Bhatt; Kailash P Bhatia
Journal:  Mov Disord       Date:  2013-06-04       Impact factor: 10.338

Review 7.  Clinical features and pharmacotherapy of childhood monoamine neurotransmitter disorders.

Authors:  J Ng; S J R Heales; M A Kurian
Journal:  Paediatr Drugs       Date:  2014-08       Impact factor: 3.022

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.